DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+3.05%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$15.4B
AUM Growth
+$758M
(+5.2%)
Cap. Flow
+$361M
Cap. Flow
% of AUM
2.35%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
1,277
New
124
Increased
437
Reduced
439
Closed
64
Top Buys
| 1 |
Cisco
CSCO
|
$75.4M |
| 2 |
Merck
MRK
|
$58.7M |
| 3 |
AT&T
T
|
$48.4M |
| 4 |
Exxon Mobil
XOM
|
$43.8M |
| 5 |
Duke Energy
DUK
|
$40.4M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
$130M |
| 2 |
Apple
AAPL
|
$54.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
$48.4M |
| 4 |
3M
MMM
|
$44.6M |
| 5 |
Deutsche Bank
DB
|
$31.6M |
Sector Composition
| 1 | Technology | 19.26% |
| 2 | Financials | 15.29% |
| 3 | Healthcare | 15.13% |
| 4 | Communication Services | 10.15% |
| 5 | Consumer Discretionary | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Prothena Corp
PRTA
$460M
| $233K | ﹤0.01% |
15,850
| – | – |
|
1027
Dycom Industries
DY
$7.19B
| $232K | ﹤0.01% |
2,450
+1,350
| +123% | +$128K |
|
1028
BioCryst Pharmaceuticals
BCRX
$1.74B
| $229K | ﹤0.01% |
39,500
| – | – |
|
1029
Gray Television
GTN
$625M
| $226K | ﹤0.01% |
14,179
+1,158
| +9% | +$18.5K |
|
1030
Grupo Aeroportuario del Pacifico
PAC
$12.6B
| $225K | ﹤0.01% |
2,368
| – | – |
|
1031
MasTec
MTZ
$14B
| $222K | ﹤0.01% |
4,430
+1,960
| +79% | +$98.2K |
|
|
FPRX
1032
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $221K | ﹤0.01% |
14,200
-260,000
| -95% | -$4.05M |
|
1033
MKS Inc. Common Stock
MKSI
$7.02B
| $220K | ﹤0.01% |
+2,349
| New | +$220K |
|
|
PGNX
1034
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $219K | ﹤0.01% |
27,000
+18,000
| +200% | +$146K |
|
|
CBIO
1035
Crescent Biopharma, Inc. Common Stock
CBIO
$198M
| $216K | ﹤0.01% |
137
| – | – |
|
|
INSY
1036
DELISTED
Insys Therapeutics, Inc.
INSY
| $214K | ﹤0.01% |
29,000
| – | – |
|
1037
Kura Oncology
KURA
$713M
| $213K | ﹤0.01% |
12,300
| – | – |
|
1038
Assertio
ASRT
$76.8M
| $211K | ﹤0.01% |
7,675
| – | – |
|
1039
Eagle Materials
EXP
$7.86B
| $210K | ﹤0.01% |
2,000
+890
| +80% | +$93.5K |
|
1040
Vanda Pharmaceuticals
VNDA
$272M
| $209K | ﹤0.01% |
10,900
| – | – |
|
1041
American Airlines Group
AAL
$8.63B
| $208K | ﹤0.01% |
5,057
-5,777
| -53% | -$238K |
|
1042
Chord Energy
CHRD
$5.92B
| $207K | ﹤0.01% |
15,634
+11,284
| +259% | +$149K |
|
1043
U-Haul Holding Co
UHAL
$11.2B
| $206K | ﹤0.01% |
5,450
+440
| +9% | +$16.6K |
|
1044
Trinseo
TSE
$88.1M
| $205K | ﹤0.01% |
2,894
| – | – |
|
1045
Abercrombie & Fitch
ANF
$4.49B
| $204K | ﹤0.01% |
+8,062
| New | +$204K |
|
1046
PBF Energy
PBF
$3.3B
| $202K | ﹤0.01% |
+4,851
| New | +$202K |
|
|
USG
1047
DELISTED
Usg
USG
| $201K | ﹤0.01% |
4,650
+1,370
| +42% | +$59.2K |
|
1048
Ovintiv
OVV
$10.6B
| $199K | ﹤0.01% |
3,044
| – | – |
|
1049
KBR
KBR
$6.4B
| $197K | ﹤0.01% |
11,050
+4,770
| +76% | +$85K |
|
|
ACHN
1050
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $195K | ﹤0.01% |
68,300
| – | – |
|